Selected research
Market Outlook & Growth Opportunities
Global Biliary and Pancreatic Drainage Stent Market Outlook and Growth Opportunities 2026
Market perspective
The global Biliary and Pancreatic Drainage Stent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Biliary and Pancreatic Drainage Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biliary and Pancreatic Drainage Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biliary and Pancreatic Drainage Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Biliary and Pancreatic Drainage Stent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Biliary and Pancreatic Drainage Stent market include Boston Scientific Corporation, Merit Medical Systems, Inc., Cook Medical, Olympus, ENDO-FLEX GmbH, Neuromedex, Hobbs Medical, Medtronic and Taewoong Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Biliary and Pancreatic Drainage Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biliary and Pancreatic Drainage Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biliary and Pancreatic Drainage Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biliary and Pancreatic Drainage Stent market size, projected growth trends, production technologies, key applications, and end-use industries.
Biliary and Pancreatic Drainage Stent Segment by Company
Boston Scientific Corporation
Merit Medical Systems, Inc.
Cook Medical
Olympus
ENDO-FLEX GmbH
Neuromedex
Hobbs Medical
Medtronic
Taewoong Medical
ELLA-CS
BD
Biliary and Pancreatic Drainage Stent Segment by Type
Biodegradable Material
Polymer Material
Metal Material
Others
Biliary and Pancreatic Drainage Stent Segment by Application
Hospitals
Clinics
Others
Biliary and Pancreatic Drainage Stent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Biliary and Pancreatic Drainage Stent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Biliary and Pancreatic Drainage Stent market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biliary and Pancreatic Drainage Stent significant trends, drivers, influence factors in global and regions.
6. To analyze Biliary and Pancreatic Drainage Stent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biliary and Pancreatic Drainage Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biliary and Pancreatic Drainage Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biliary and Pancreatic Drainage Stent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biliary and Pancreatic Drainage Stent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biliary and Pancreatic Drainage Stent industry.
Chapter 3: Detailed analysis of Biliary and Pancreatic Drainage Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Biliary and Pancreatic Drainage Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Biliary and Pancreatic Drainage Stent in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Biodegradable Material
- Polymer Material
- Metal Material
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Boston Scientific Corporation
- Merit Medical Systems, Inc.
- Cook Medical
- Olympus
- ENDO-FLEX GmbH
- Neuromedex
- Hobbs Medical
- Medtronic
- Taewoong Medical
- ELLA-CS
- BD
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Biliary and Pancreatic Drainage Stent Sales Value (2021-2032)
- 1.2.2 Global Biliary and Pancreatic Drainage Stent Sales Volume (2021-2032)
- 1.2.3 Global Biliary and Pancreatic Drainage Stent Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Biliary and Pancreatic Drainage Stent Market Dynamics
- 2.1 Biliary and Pancreatic Drainage Stent Industry Trends
- 2.2 Biliary and Pancreatic Drainage Stent Industry Drivers
- 2.3 Biliary and Pancreatic Drainage Stent Industry Opportunities and Challenges
- 2.4 Biliary and Pancreatic Drainage Stent Industry Restraints
3 Biliary and Pancreatic Drainage Stent Market by Company
- 3.1 Global Biliary and Pancreatic Drainage Stent Company Revenue Ranking in 2025
- 3.2 Global Biliary and Pancreatic Drainage Stent Revenue by Company (2021-2026)
- 3.3 Global Biliary and Pancreatic Drainage Stent Sales Volume by Company (2021-2026)
- 3.4 Global Biliary and Pancreatic Drainage Stent Average Price by Company (2021-2026)
- 3.5 Global Biliary and Pancreatic Drainage Stent Company Ranking (2024-2026)
- 3.6 Global Biliary and Pancreatic Drainage Stent Company Manufacturing Base and Headquarters
- 3.7 Global Biliary and Pancreatic Drainage Stent Company Product Type and Application
- 3.8 Global Biliary and Pancreatic Drainage Stent Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Biliary and Pancreatic Drainage Stent Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Biliary and Pancreatic Drainage Stent Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Biliary and Pancreatic Drainage Stent Market by Type
- 4.1 Biliary and Pancreatic Drainage Stent Type Introduction
- 4.1.1 Biodegradable Material
- 4.1.2 Polymer Material
- 4.1.3 Metal Material
- 4.1.4 Others
- 4.2 Global Biliary and Pancreatic Drainage Stent Sales Volume by Type
- 4.2.1 Global Biliary and Pancreatic Drainage Stent Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biliary and Pancreatic Drainage Stent Sales Volume by Type (2021-2032)
- 4.2.3 Global Biliary and Pancreatic Drainage Stent Sales Volume Share by Type (2021-2032)
- 4.3 Global Biliary and Pancreatic Drainage Stent Sales Value by Type
- 4.3.1 Global Biliary and Pancreatic Drainage Stent Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biliary and Pancreatic Drainage Stent Sales Value by Type (2021-2032)
- 4.3.3 Global Biliary and Pancreatic Drainage Stent Sales Value Share by Type (2021-2032)
5 Biliary and Pancreatic Drainage Stent Market by Application
- 5.1 Biliary and Pancreatic Drainage Stent Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Biliary and Pancreatic Drainage Stent Sales Volume by Application
- 5.2.1 Global Biliary and Pancreatic Drainage Stent Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biliary and Pancreatic Drainage Stent Sales Volume by Application (2021-2032)
- 5.2.3 Global Biliary and Pancreatic Drainage Stent Sales Volume Share by Application (2021-2032)
- 5.3 Global Biliary and Pancreatic Drainage Stent Sales Value by Application
- 5.3.1 Global Biliary and Pancreatic Drainage Stent Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biliary and Pancreatic Drainage Stent Sales Value by Application (2021-2032)
- 5.3.3 Global Biliary and Pancreatic Drainage Stent Sales Value Share by Application (2021-2032)
6 Biliary and Pancreatic Drainage Stent Regional Sales and Value Analysis
- 6.1 Global Biliary and Pancreatic Drainage Stent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biliary and Pancreatic Drainage Stent Sales by Region (2021-2032)
- 6.2.1 Global Biliary and Pancreatic Drainage Stent Sales by Region: 2021-2026
- 6.2.2 Global Biliary and Pancreatic Drainage Stent Sales by Region (2027-2032)
- 6.3 Global Biliary and Pancreatic Drainage Stent Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Biliary and Pancreatic Drainage Stent Sales Value by Region (2021-2032)
- 6.4.1 Global Biliary and Pancreatic Drainage Stent Sales Value by Region: 2021-2026
- 6.4.2 Global Biliary and Pancreatic Drainage Stent Sales Value by Region (2027-2032)
- 6.5 Global Biliary and Pancreatic Drainage Stent Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Biliary and Pancreatic Drainage Stent Sales Value (2021-2032)
- 6.6.2 North America Biliary and Pancreatic Drainage Stent Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Biliary and Pancreatic Drainage Stent Sales Value (2021-2032)
- 6.7.2 Europe Biliary and Pancreatic Drainage Stent Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Biliary and Pancreatic Drainage Stent Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Biliary and Pancreatic Drainage Stent Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Biliary and Pancreatic Drainage Stent Sales Value (2021-2032)
- 6.9.2 South America Biliary and Pancreatic Drainage Stent Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Biliary and Pancreatic Drainage Stent Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Biliary and Pancreatic Drainage Stent Sales Value Share by Country, 2025 VS 2032
7 Biliary and Pancreatic Drainage Stent Country-level Sales and Value Analysis
- 7.1 Global Biliary and Pancreatic Drainage Stent Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biliary and Pancreatic Drainage Stent Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Biliary and Pancreatic Drainage Stent Sales by Country (2021-2032)
- 7.3.1 Global Biliary and Pancreatic Drainage Stent Sales by Country (2021-2026)
- 7.3.2 Global Biliary and Pancreatic Drainage Stent Sales by Country (2027-2032)
- 7.4 Global Biliary and Pancreatic Drainage Stent Sales Value by Country (2021-2032)
- 7.4.1 Global Biliary and Pancreatic Drainage Stent Sales Value by Country (2021-2026)
- 7.4.2 Global Biliary and Pancreatic Drainage Stent Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.9.2 France Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.16.2 China Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.19.2 India Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Biliary and Pancreatic Drainage Stent Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Biliary and Pancreatic Drainage Stent Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Biliary and Pancreatic Drainage Stent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Boston Scientific Corporation
- 8.1.1 Boston Scientific Corporation Company Information
- 8.1.2 Boston Scientific Corporation Business Overview
- 8.1.3 Boston Scientific Corporation Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Boston Scientific Corporation Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.1.5 Boston Scientific Corporation Recent Developments
- 8.2 Merit Medical Systems, Inc.
- 8.2.1 Merit Medical Systems, Inc. Company Information
- 8.2.2 Merit Medical Systems, Inc. Business Overview
- 8.2.3 Merit Medical Systems, Inc. Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Merit Medical Systems, Inc. Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.2.5 Merit Medical Systems, Inc. Recent Developments
- 8.3 Cook Medical
- 8.3.1 Cook Medical Company Information
- 8.3.2 Cook Medical Business Overview
- 8.3.3 Cook Medical Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Cook Medical Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.3.5 Cook Medical Recent Developments
- 8.4 Olympus
- 8.4.1 Olympus Company Information
- 8.4.2 Olympus Business Overview
- 8.4.3 Olympus Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Olympus Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.4.5 Olympus Recent Developments
- 8.5 ENDO-FLEX GmbH
- 8.5.1 ENDO-FLEX GmbH Company Information
- 8.5.2 ENDO-FLEX GmbH Business Overview
- 8.5.3 ENDO-FLEX GmbH Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.5.4 ENDO-FLEX GmbH Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.5.5 ENDO-FLEX GmbH Recent Developments
- 8.6 Neuromedex
- 8.6.1 Neuromedex Company Information
- 8.6.2 Neuromedex Business Overview
- 8.6.3 Neuromedex Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Neuromedex Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.6.5 Neuromedex Recent Developments
- 8.7 Hobbs Medical
- 8.7.1 Hobbs Medical Company Information
- 8.7.2 Hobbs Medical Business Overview
- 8.7.3 Hobbs Medical Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Hobbs Medical Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.7.5 Hobbs Medical Recent Developments
- 8.8 Medtronic
- 8.8.1 Medtronic Company Information
- 8.8.2 Medtronic Business Overview
- 8.8.3 Medtronic Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Medtronic Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.8.5 Medtronic Recent Developments
- 8.9 Taewoong Medical
- 8.9.1 Taewoong Medical Company Information
- 8.9.2 Taewoong Medical Business Overview
- 8.9.3 Taewoong Medical Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Taewoong Medical Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.9.5 Taewoong Medical Recent Developments
- 8.10 ELLA-CS
- 8.10.1 ELLA-CS Company Information
- 8.10.2 ELLA-CS Business Overview
- 8.10.3 ELLA-CS Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.10.4 ELLA-CS Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.10.5 ELLA-CS Recent Developments
- 8.11 BD
- 8.11.1 BD Company Information
- 8.11.2 BD Business Overview
- 8.11.3 BD Biliary and Pancreatic Drainage Stent Sales, Value and Gross Margin (2021-2026)
- 8.11.4 BD Biliary and Pancreatic Drainage Stent Product Portfolio
- 8.11.5 BD Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Biliary and Pancreatic Drainage Stent Value Chain Analysis
- 9.1.1 Biliary and Pancreatic Drainage Stent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biliary and Pancreatic Drainage Stent Sales Mode & Process
- 9.2 Biliary and Pancreatic Drainage Stent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biliary and Pancreatic Drainage Stent Distributors
- 9.2.3 Biliary and Pancreatic Drainage Stent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst